A method for preparing recombinant blue copper peptide GHK
By optimizing GHK gene expression in Escherichia coli and purifying it using Ni-NTA chromatography, the high cost of chemically synthesized blue copper peptide GHK was solved, enabling low-cost preparation of recombinant GHK.
Patent Information
- Application Number
- CN202611591105.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-10-14
- Publication Date
- 2026-11-17
AI Technical Summary
Existing chemical synthesis of blue copper peptide GHK is costly, relying on expensive condensation reagents and large amounts of organic solvents.
Using a prokaryotic expression optimization method, the GHK gene was cloned into the pET-28a(+) vector, and expression was controlled using the T7 promoter and LacI system. IPTG was added to induce expression, and the natural GHK was obtained by Ni-NTA chromatography purification and excision of the fusion tag.
This reduces the preparation cost of blue copper peptide GHK and enables efficient and low-cost expression and purification in the E. coli system.
Smart Images

Figure CN123106927A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of peptide synthesis technology, specifically relating to a method for preparing recombinant blue copper peptide GHK. Background Technology
[0002] The tripeptide Gly-His-Lys (GHK) possesses significant tissue repair and collagen regeneration effects and is considered one of the representative early "signal peptides" in research. GHK-Cu not only exhibits important biological activities in skin repair, anti-inflammation, and anti-oxidation, but is also closely related to metal ion transport, cell proliferation, and gene regulation. In a dermal fibroblast model, GHK-Cu promotes the synthesis of extracellular matrix (ECM) components (such as collagen and decorative proteins) while regulating the balance of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). This mechanism provides the molecular basis for its function in tissue remodeling and anti-aging. GHK-Cu can affect fibroblast signaling pathways and the expression of anti-inflammatory genes, thereby promoting cell repair and antioxidant capacity. The breadth of these physiological functions forms the basis for its widespread attention in cosmetic research and regenerative medicine. Gene chip analysis results show that GHK-Cu can upregulate repair-related genes while inhibiting the activation of inflammatory pathways such as NF-κB, providing molecular-level evidence for its anti-aging and anti-inflammatory effects.
[0003] GHK has a simple structure, consisting of only three amino acids, and its preparation has long relied primarily on chemical synthesis. While chemical synthesis can produce GHK, its dependence on high-purity protective amino acids, expensive condensation reagents (such as HBTU, HBTU / HOBt), and large amounts of organic solvents (such as DMF and DCM) has made this route prohibitively expensive. Summary of the Invention
[0004] To address the shortcomings of the existing technology, this invention provides a method for preparing recombinant blue copper peptide GHK, which can solve the technical problem of high cost of existing chemical synthesis of blue copper peptide GHK.
[0005] Since GHK is an artificially designed short peptide sequence, its naturally derived codons are not suitable for the *E. coli* expression system. Therefore, this invention re-optimized the prokaryotic expression of the target gene to improve the translation efficiency and expression level of the exogenous gene in the host bacterium. Subsequently, the optimized GHK gene was cloned into the prokaryotic expression vector pET-28a(+) to construct the recombinant expression plasmid pET-28a-GHK. This plasmid uses the T7 promoter as the core promoter system. Near the T7 promoter, there is also a lac operator, whose function is to regulate the expression of the target gene through LacI inhibitory protein, reducing the leakage expression of exogenous protein under uninduced conditions. When IPTG is added, LacI binds to and inactivates IPTG, thereby relieving the inhibition and initiating the transcription of the target gene. A 6×His tag sequence (6His) is attached before and after GHK, mainly to facilitate subsequent protein purification and detection. The His tag can specifically bind to a nickel ion affinity column, so Ni-NTA metal chelate chromatography can be used to purify the expression product. The thrombin site is also present, allowing the fusion tag to be cleaved using thrombin after purification, thus obtaining a more natural GHK. This invention is achieved through the following technical solution:
[0006] A method for preparing recombinant blue copper peptide GHK includes the following steps: The sequence expressing the recombinant blue copper peptide GHK was inserted into the expression vector to obtain the recombinant vector; The sequence of the recombinant vector is shown in SEQ ID NO.1; The recombinant expression vector was introduced into engineered bacteria to obtain recombinant engineered bacteria; Lactose operon inducer was added to the culture medium of recombinant engineered bacteria to obtain recombinant copper peptide GHK.
[0007] Furthermore, the recombinant vector uses pET-28a(+) as its backbone, SEQ ID NO.2 as its promoter, and SEQ ID NO.3 as its coding region.
[0008] Furthermore, the backbone of the recombinant vector is pET-28a(+).
[0009] Furthermore, the recombinant vector also contains a T7 promoter, a lac operator, a thrombin site, a 6×His tag sequence, and a Kanamycin resistance selection marker. The sequence expressing the recombinant blue copper peptide GHK is linked with a 6×His tag sequence (6His), which mainly facilitates subsequent protein purification and detection. The His tag can specifically bind to a nickel ion affinity column, so the expression product can be purified by Ni-NTA metal chelate chromatography. The thrombin site is a thrombin cleavage site, and after purification, the fusion tag can be cleaved by thrombin to obtain a more native state of GHK.
[0010] Furthermore, the sequence expressing the recombinant blue copper peptide GHK is inserted into the expression vector at a site between NdeI and XhoI.
[0011] Furthermore, the engineered bacteria include Escherichia coli (E. coli) Escherichia coli ).
[0012] Furthermore, the lactose operon inducer includes isopropyl-β-D-thiogalactoside.
[0013] Furthermore, isopropyl-β-D-thiogalactoside was added to the culture medium of the recombinant engineered bacteria to a final concentration of 0.08~0.12 mmol / L.
[0014] Furthermore, isopropyl-β-D-thiogalactoside was added to the culture medium for the recombinant engineered bacteria to a final concentration of 0.1 mmol / L.
[0015] Furthermore, isopropyl-β-D-thiogalactoside was added to the culture medium for the recombinant engineered bacteria to a final concentration of 0.08 mmol / L.
[0016] Furthermore, isopropyl-β-D-thiogalactoside was added to the culture medium of the recombinant engineered bacteria to a final concentration of 0.12 mmol / L.
[0017] Furthermore, the culture temperature of the recombinant engineered bacteria is 35℃~39℃.
[0018] Furthermore, the culture temperature of the recombinant engineered bacteria is 35°C.
[0019] Furthermore, the culture temperature of the recombinant engineered bacteria is 39°C.
[0020] Compared with the prior art, the beneficial effects of the present invention are as follows: This invention provides a method for preparing recombinant copper peptide GHK, comprising the following steps: inserting the sequence expressing recombinant copper peptide GHK into an expression vector to obtain a recombinant vector; the recombinant vector uses pET-28a(+) as a backbone, SEQ ID NO.2 as a promoter, and SEQ ID NO.3 as a coding region; introducing the recombinant expression vector into engineered bacteria to obtain recombinant engineered bacteria; adding a lactose operon inducer to the culture medium of the recombinant engineered bacteria to induce expression, thereby obtaining recombinant copper peptide GHK. This method eliminates the need for expensive condensation reagents, resulting in a low cost for synthesizing recombinant copper peptide GHK. The 28×GHK tandem fusion protein was successfully synthesized in... E. coli Induced expression in prokaryotic expression systems. Attached Figure Description
[0021] Figure 1 This is a schematic diagram of GHK single-clone colonies, where A is a colony diagram of colonies cultured in the culture medium; B is a single-clone colony picked; the arrows and circles indicate the locations where single-clone colonies were picked.
[0022] Figure 2 This is an electrophoresis image of nucleic acid used to verify the PCR extraction of plasmid from a single GHK colony. 1 represents the PCR result of a single GHK plasmid at a Tm value of 55.8℃; M represents the marker; the arrow indicates the target fragment.
[0023] Figure 3 The graph shows the protein expression results of GHK under 0.1 mmol / L IPTG induction; 1 represents pre-induction protein; 2 represents post-induction protein; 3 represents total fragmented protein; 4 represents supernatant protein after fragmentation; 5 represents precipitated protein after fragmentation; M represents Protein Marker; the arrows indicate the target protein.
[0024] Figure 4 This is a TLC detection result image; 1 represents GHK standard; 2 represents the sample to be tested; 3 represents buffer blank control; 4 represents deionized water blank control; the arrows indicate the yellow-purple spots that appear in the same position. Detailed Implementation
[0025] The specific embodiments of the present invention are described in detail below, but it should be understood that the scope of protection of the present invention is not limited to the specific embodiments. All other embodiments obtained by those skilled in the art based on the embodiments of the present invention without creative effort are within the scope of protection of the present invention. Unless otherwise specified, the experimental methods described in the embodiments of the present invention are conventional methods. Specific explanations are needed as follows:
[0026] Gly-His-Lys tripeptide, abbreviated as GHK; isopropyl-β-D-thiogalactoside, abbreviated as IPTG.
[0027] Preparation method of liquid LB medium: Accurately weigh 1g Tryptone, 0.5g Yeast Extract, and 1g NaCl using an electronic balance, place them in a beaker, add 100mL ddH2O to the beaker, and stir thoroughly. Dispense the mixed liquid LB medium into 5mL portions using a syringe into test tubes, autoclave at 121℃ for 20min, and store in a sealed container at room temperature before use.
[0028] Preparation of solid LB medium: Accurately weigh 1g Tryptone, 0.5g Yeast Extract, 1g NaCl, and 1.5g Agar powder using an electronic balance and place them in an Erlenmeyer flask. Add 100mL ddH2O to the flask and stir thoroughly to ensure complete dissolution of each component. Seal the flask tightly with sealing film and sterilize it in an autoclave at 121℃ for 20min. Remove the flask and place it in a laminar flow hood to cool naturally to 50℃. Using a pipette, add 100μL of 100mg / mL Kan antibiotic and 200μL of phage inhibitor to the flask, and gently shake to mix. Pour the medium into sterilized Petri dishes until solidified, seal tightly with sealing film, and store upside down in a refrigerator at 4℃.
[0029] Preparation method of 2×YT medium: Accurately weigh 1.6g Tryptone, 1g Yeast Extract, and 0.5g NaCl using an electronic balance, place them in a beaker, add 100mL ddH2O to the beaker, and stir thoroughly. Adjust the pH to 8.0 using a pH meter, sterilize in an autoclave at 121℃ for 20min, and store in a sealed container at room temperature before use.
[0030] Preparation method of 1 mol / L IPTG: Accurately weigh 2.383 g IPTG using an electronic balance and place it in a 15 mL EP tube. Add 10 mL of ddH2O to the EP tube, filter it using a sterilized filter in a clean bench, dispense it into 1.5 mL EP tubes, and store it in a -20℃ refrigerator.
[0031] The target gene sequence for expressing the copper peptide GHK (Gly-His-Lys) was determined using the GenBank database on the NCBI website and relevant literature. Since GHK is an artificially designed short peptide sequence, its naturally derived codons are not suitable for the *E. coli* expression system. Therefore, based on *E. coli*... Escherichia coliCodon bias was used to optimize the prokaryotic expression of the target gene to improve the translation efficiency and expression level of the exogenous gene in the host bacteria. The optimized GHK gene was then cloned into the prokaryotic expression vector pET-28a(+), constructing the recombinant expression plasmid pET-28a-GHK. This plasmid uses the T7 promoter as the core promoter system. Near the T7 promoter, there is a lac operator, whose function is to regulate the expression of the target gene through LacI inhibitory protein, reducing the leakage expression of exogenous protein under uninduced conditions. When IPTG is added, LacI binds to IPTG and becomes inactive, thereby relieving the inhibition and initiating the transcription of the target gene. A 6×His tag sequence (6His) is attached before and after GHK, mainly to facilitate subsequent protein purification and detection. The His tag can specifically bind to a nickel ion affinity column, so Ni-NTA metal chelate chromatography can be used to purify the expression product. A thrombin site is also present; after purification, thrombin can be used to remove the fusion tag, thus obtaining a more native state of GHK.
[0032] Example 1: A method for preparing recombinant blue copper peptide GHK, the specific steps of which are as follows: S1. Insert the sequence expressing recombinant blue copper peptide GHK into the pET-28a(+) plasmid to obtain the recombinant vector, namely the recombinant expression plasmid pET-28a-GHK; the sequence of the recombinant vector is shown in SEQ ID NO.1; TAATACGACTCACTATAGGGGAATTG TGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACC atgggcagcagccatcatcatcatcacagcagcggcctggtgccgcgcggcagccatatgaaaggtcataaaggtcataaaggtcataaaggtcataaaggtcataaaggtcata aaggtcataaaggtcataaaggtcataaaggtcataaaggtcataaaggtcataaaggtcataaaggtcataaaggtcataaaggtcataaaggtcataaaggtcataaaggtcataa aggtcataaaggtcataaaggtcataaaggtcataaaggtcataaaggtcataaaggtcataaataaCTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGA AAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT-3', SEQ ID NO.1, the single underscore represents the promoter portion of the pET-28a plasmid sequence, denoted as SEQ ID NO.2; the lowercase letter represents the poly-GHK coding region (ORF), denoted as SEQ ID NO.3; the double underscore represents the downstream XhoI restriction endonuclease site.
[0033] S2. The recombinant expression vector was introduced into the E. coli BL21(DE3) expression strain and the recombinant engineered strain was obtained in LB liquid medium containing Kan antibiotic and phage inhibitor. The recombinant engineered bacteria were cultured at 37℃ and 180 rpm for 12 h with shaking. Then, they were transferred to 2×YT liquid medium at a volume ratio of 1:100 for expansion culture. When the OD600 of the bacterial culture reached 0.5, IPTG was added to induce expression. The final concentration of IPTG in the 2×YT liquid medium was 0.1 mmol / L. After 4 h, the bacterial cells were collected, centrifuged, broken, purified, digested with enzymes, and ultrafiltered to obtain the recombinant blue copper peptide GHK.
[0034] Experiment 1 Construction of GHK plasmid Based on the amino acid sequence of the blue copper peptide GHK, combined with E. coliCodon preference was used to optimize the design of the target gene. To improve the stability and expression level of the expression product, a 28×GHK tandem repeat expression strategy was used to construct the target gene sequence. The optimized target gene was synthesized and cloned into the prokaryotic expression vector pET-28a(+) to construct the recombinant expression plasmid pET-28a-GHK. After plasmid construction, it was preserved in skeletal culture form.
[0035] The recombinant expression plasmid pET-28a-GHK, which was constructed, was used for prokaryotic expression. This plasmid uses pET-28a(+) as the vector backbone and contains a T7 promoter, a Kanamycin resistance selection marker, and a 6×His tag sequence, which can achieve efficient induction of the target gene in the E. coli expression system.
[0036] Experiment 2: Induced expression of GHK The pET-28a-GHK recombinant plasmid, verified by PCR and sequencing, was transformed into E. coli BL21(DE3) expression strain. Positive single colonies were picked and inoculated into LB liquid medium containing Kans antibiotic and phage inhibitor, and cultured at 37°C and 180 rpm for 12 h with shaking. Then, the culture was expanded by transferring the plasmid to 2×YT liquid medium at a 1:100 ratio. When the OD600 of the bacterial culture reached 0.4–0.6, IPTG was added to induce expression.
[0037] Before formal induction of expression, preliminary experiments were conducted to optimize the IPTG concentration. After induction at 37℃ and 110 rpm for 4 hours, it was found that the bacterial OD600 increased from 0.6 to 1.1 under 0.1 mmol / L IPTG, while the OD600 only increased from approximately 0.5 to 0.75 under 0.5 mmol / L and 1 mmol / L IPTG, indicating that high concentrations of IPTG significantly inhibited the growth of engineered bacteria. This may be because high concentrations of IPTG lead to overactivation of the T7 expression system, resulting in excessive expression of the target peptide and thus increasing the metabolic burden on the host cell; simultaneously, the GHK tandem repeat sequence may have certain cytotoxicity, and the toxic effect is further amplified under high expression conditions, leading to slowed bacterial growth. In addition, lower concentrations of IPTG are more conducive to improving the soluble expression of recombinant proteins in prokaryotic expression systems for small molecule bioactive peptides, and the IPTG concentration is usually best controlled within the range of 0.1~0.5 mmol / L. Therefore, 0.1 mmol / L IPTG was ultimately selected as the induction concentration for GHK prokaryotic expression. Based on the preliminary experimental results, 0.1 mmol / L IPTG was selected as the induction concentration, and induction was performed at 37℃ and 110 rpm for 4 h. After induction, the bacterial cells were collected, centrifuged to obtain the bacterial cell precipitate, and used for subsequent protein electrophoresis analysis and TLC detection.
[0038] like Figure 1 As shown, the colonies grown on the culture medium exhibit typical monoclonal characteristics: uniform morphology, moderate size, no adhesion or fusion between colonies, clear boundary outlines, uniform and independent distribution, and no contamination or satellite colonies. To ensure the accuracy of the experiment, the bacterial strains used in subsequent experiments were all taken from the single colonies circled in the figure.
[0039] Using GHK as a template, plasmids extracted from selected single colonies were subjected to PCR, and electrophoresis was performed as follows: Figure 2 As shown, based on the primer design, the theoretical size of the target fragment is 457 bp. Figure 2 As can be seen, a clear, bright, and single DNA band appeared at approximately 450 bp in lane 1, and its migration position was basically consistent with the theoretically expected size. Comparison with DNA marker analysis showed that the size of the amplified product met the target fragment length requirements. Furthermore, no obvious non-specific amplification bands or primer dimer bands were observed in the electrophoresis results, indicating that the designed primers had good amplification specificity and efficiency. The high brightness and clear edges of the target band indicated that the PCR amplification reaction proceeded smoothly, and the amplified product concentration was high and of good purity. Since the amplified product was mainly concentrated at the target position without obvious tailing, it indicated that the template quality was good and the PCR system and annealing temperature settings were reasonable.
[0040] The PCR products of the recombinant plasmid were subjected to bidirectional sequencing, and the sequencing results were compared with the reference sequence using BLAST analysis. Both sequences were completely matched with the reference sequence, with a 100% identity. The E-values for both alignments were 0.0, indicating that the sequence matching results were highly statistically significant and not due to random matching. These results confirm that the target gene has been correctly inserted into the vector backbone, and the recombinant plasmid sequence is completely consistent with the design and can be used for subsequent experimental research.
[0041] Experiment 2: SDS-PAGE detection results of GHK After induction with IPTG at a final concentration of 0.1 mmol / L, expression was performed at 37℃, 110 rpm, and 4 h. The protein electrophoresis results are as follows. Figure 3 As shown, after induction with IPTG at a final concentration of 0.1 mmol / L, a distinct protein band appeared at approximately 10 kDa, consistent with the theoretical relative molecular mass of approximately 10 kDa for the 28×GHK tandem fusion protein, indicating that the target protein had been induced. E. coliSuccessful expression was achieved in the prokaryotic expression system. Electrophoresis results showed that the target band was significantly darker after induction compared to before induction, indicating a significant increase in GHK fusion protein expression after IPTG induction. Further analysis of protein distribution after cell disruption revealed that the target protein band was mainly distributed in the supernatant, while no corresponding band was observed in the precipitate, indicating that the expression product exists primarily in a soluble form and did not form numerous inclusion bodies. This may be related to the lower concentration of IPTG induction reducing the expression burden on the host cells, and the fact that GHK is rich in hydrophilic amino acids and has good water solubility, thus facilitating the soluble expression of the target protein in the prokaryotic system. The results also demonstrate that high-concentration SDS-PAGE effectively separated and visualized the target protein band.
[0042] Experiment 3: TLC detection results of GHK The expression product was qualitatively analyzed using thin-layer chromatography (TLC) combined with ninhydrin colorimetric method.
[0043] TLC is a simple, low-cost, and fast detection method with high sensitivity for small molecule peptides, making it particularly suitable for detecting bioactive peptides with small molecular weights that are difficult to analyze using SDS-PAGE. Furthermore, ninhydrin reacts with the free amino groups in GHK to form characteristic purple spots, enabling rapid qualitative analysis of the target peptide. Therefore, the TLC-ninhydrin detection system used in this study can well meet the preliminary detection requirements of GHK prokaryotic expression products and provides an experimental basis for subsequent GHK research. GHK was induced with IPTG at a final concentration of 0.1 mmol / L and expressed at 37℃, 110 rpm, and for 4 h. The results are as follows: Figure 4 As shown in the TLC results, yellow-purple spots were observed at the same positions in both the GHK standard and the test sample, consistent with the typical Rf value of GHK. No spots appeared in the buffer and deionized water blank control groups, suggesting the presence of GHK in the test sample. The tailing phenomenon at the standard spotting point indicates that the standard concentration was too high. The more pronounced yellow color at the endpoint of the test sample's migration, rather than purple, also exhibited tailing. This is because the target GHK fragment is a long chain composed of 28 GHK molecules formed by dehydration condensation; it is speculated that enzymatic cleavage into single GHK molecules might enhance the colorimetric effect.
[0044] This invention successfully constructed the pET-28a-GHK recombinant plasmid using pET-28a(+) as the prokaryotic expression vector, and transformed it into the E. coli BL21(DE3) prokaryotic expression system for amplification and expression verification. The induced expression of the GHK tandem fusion protein was achieved. Codon optimization of the target gene improved its expression adaptability in E. coli. Simultaneously, by optimizing the IPTG induction concentration and establishing an SDS-PAGE analysis system suitable for the detection of small molecule bioactive peptides, the soluble expression and detection efficiency of GHK was improved. Specific results are as follows:
[0045] (1) Preliminary experiments to optimize IPTG concentration revealed that the optimal bacterial growth was achieved at 0.1 mmol / L IPTG, with OD600 increasing from 0.6 to 1.1. Higher concentrations of IPTG (0.5 mmol / L and 1 mmol / L) significantly inhibited the growth of the engineered bacteria. It is speculated that high concentrations of IPTG may lead to overactivation of the T7 expression system, thereby increasing the metabolic burden on host cells and amplifying the toxic effects of GHK tandem repeat expression. Therefore, 0.1 mmol / L IPTG was ultimately determined to be the most suitable induction concentration.
[0046] (2) This invention uses a TLC-ninhydrin colorimetric system to detect the expression product. The results show that the test sample and the GHK standard both show yellow-purple spots at the same positions, indicating the presence of GHK in the expression product. This method is simple to operate and low in cost, and is suitable for rapid qualitative analysis of small molecule bioactive peptides, providing an experimental basis for subsequent purification and functional studies of GHK.
[0047] (3) Protein electrophoresis results showed that after induction with 0.1 mmol / L IPTG, a clear target band appeared in the approximately 10 kDa range, which was basically consistent with the theoretical molecular weight of the 28×GHK tandem fusion protein, indicating that GHK had been successfully expressed. Further analysis of the protein distribution after fragmentation revealed that the target protein was mainly present in the supernatant after fragmentation, while no obvious band was observed in the precipitate, indicating that the expression product mainly existed in a soluble form and did not form a large number of inclusion bodies. It is speculated that this may be related to the fact that the low concentration of IPTG reduced the expression pressure and that GHK is rich in hydrophilic amino acids and has good water solubility.
[0048] The above descriptions are merely embodiments of the present invention, and common knowledge such as specific technical solutions and / or characteristics are not described in detail here. It should be noted that those skilled in the art can make various modifications and improvements without departing from the technical solutions of the present invention, and these should also be considered within the scope of protection of the present invention. These modifications and improvements will not affect the effectiveness of the implementation of the present invention or the practicality of the patent. The scope of protection claimed in this application should be determined by the content of its claims, and the specific embodiments described in the specification can be used to interpret the content of the claims.
Claims
1. A method for preparing recombinant blue copper peptide GHK, characterized in that, Includes the following steps: The sequence expressing the recombinant blue copper peptide GHK was inserted into the expression vector to obtain the recombinant vector, which uses pET-28a(+) as the backbone, SEQ ID NO.2 as the promoter, and SEQ ID NO.3 as the coding region. The recombinant expression vector was introduced into engineered bacteria to obtain recombinant engineered bacteria; Lactose operon inducer was added to the culture medium of recombinant engineered bacteria to induce expression, resulting in recombinant copper peptide GHK.
2. The preparation method according to claim 1, characterized in that, The sequence of the recombinant vector is shown in SEQ ID NO.
1.
3. The preparation method according to claim 1, characterized in that, The sequence for expressing the recombinant blue copper peptide GHK is inserted into the expression vector between NdeI and XhoI.
4. The preparation method according to claim 1, characterized in that, The lactose operon inducer includes isopropyl-β-D-thiogalactoside.
5. The preparation method according to claim 4, characterized in that, The final concentration of isopropyl-β-D-thiogalactoside added to the culture medium for the recombinant engineered bacteria was 0.08~0.12 mmol / L.
6. The preparation method according to claim 5, characterized in that, The final concentration of isopropyl-β-D-thiogalactoside added to the culture medium for the recombinant engineered bacteria was 0.1 mmol / L.
7. The preparation method according to claim 1, characterized in that, The engineered bacteria include Escherichia coli ( Escherichia coli ).
8. The preparation method according to claim 1, characterized in that, The culture temperature for the recombinant engineered bacteria is 35℃~39℃.
